Alkylresorcinols as New Modulators of the Metabolic Activity of the Gut Microbiota

被引:2
|
作者
Zabolotneva, Anastasia A. [1 ,2 ]
Gaponov, Andrei M. [3 ]
Roumiantsev, Sergey A. [1 ,2 ]
Vasiliev, Ilya Yu. [4 ]
Grigoryeva, Tatiana V. [4 ]
Kit, Oleg I. [5 ]
Zlatnik, Elena Yu. [5 ]
Maksimov, Aleksey Yu. [5 ]
Goncharova, Anna S. [5 ]
Novikova, Inna A. [5 ]
Appolonova, Svetlana A. [6 ]
Markin, Pavel A. [6 ]
Shestopalov, Aleksandr V. [1 ,2 ,7 ]
机构
[1] NI Pirogov Russian Natl Res Med Univ, Fac Med, Dept Biochem & Mol Biol, 1 Ostrovitianov Str, Moscow 117997, Russia
[2] Russian Natl Med Res Ctr Endocrinol, 11 Dm Ulyanova Str, Moscow 117036, Russia
[3] Ctr Digital & Translat Biomed, Ctr Mol Hlth, 32 Nakhimovskiy Prospekt, Moscow 117218, Russia
[4] Kazan Fed Univ, Inst Fundamental Med & Biol, 18 Kremlyovskaya St, Kazan 420008, Russia
[5] Natl Med Res Ctr Oncol, 14 Line,63, Rostov Na Donu 344019, Russia
[6] Sechenov First Moscow State Med Univ, Inst Translat Med & Biotechnol, Lab Pharmacokinet & Metabol Anal, 2-4 Bolshaya Pirogovskaya St, Moscow 119991, Russia
[7] Rogachev Natl Med Res Ctr Pediat Hematol Oncol & I, 1 Samory Mashela Str, Moscow 117997, Russia
关键词
alkylresorcinols; olivetol; gut microbiota; faecal microbiota transplantation; reconstruction of gut microbiota metabolic activity; III POLYKETIDE SYNTHASE; INTESTINAL MICROBIOTA; POLYPHENOLS; OBESITY; LIPIDS;
D O I
10.3390/ijms241814206
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alkylresorcinols (ARs) are polyphenolic compounds with a wide spectrum of biological activities and are potentially involved in the regulation of host metabolism. The present study aims to establish whether ARs can be produced by the human gut microbiota and to evaluate alterations in content in stool samples as well as metabolic activity of the gut microbiota of C57BL, db/db, and LDLR (-/-) mice according to diet specifications and olivetol (5-n-pentylresorcinol) supplementation to estimate the regulatory potential of ARs. Gas chromatography with mass spectrometric detection was used to quantitatively analyse AR levels in mouse stool samples; faecal microbiota transplantation (FMT) from human donors to germ-free mice was performed to determine whether the intestinal microbiota could produce AR molecules; metagenome sequencing analysis of the mouse gut microbiota followed by reconstruction of its metabolic activity was performed to investigate olivetol's regulatory potential. A significant increase in the amounts of individual members of AR homologues in stool samples was revealed 14 days after FMT. Supplementation of 5-n-Pentylresorcinol to a regular diet influences the amounts of several ARs in the stool of C57BL/6 and LDLR (-/-) but not db/db mice, and caused a significant change in the predicted metabolic activity of the intestinal microbiota of C57BL/6 and LDLR (-/-) but not db/db mice. For the first time, we have shown that several ARs can be produced by the intestinal microbiota. Taking into account the dependence of AR levels in the gut on olivetol supplementation and microbiota metabolic activity, AR can be assumed to be potential quorum-sensing molecules, which also influence gut microbiota composition and host metabolism.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Gut Microbiota and the Gut-Brain Axis: New Insights in the Pathophysiology of Metabolic Syndrome
    de Clercq, Nicolien C.
    Frissen, Myrthe N.
    Groen, Albert K.
    Nieuwdorp, Max
    PSYCHOSOMATIC MEDICINE, 2017, 79 (08): : 874 - 879
  • [22] Gut microbiota regulates key modulators of social behavior
    Parashar, Arun
    Udayabanu, Malairaman
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (01) : 78 - 91
  • [23] Bile acids as modulators of gut microbiota composition and function
    Larabi, Anais B.
    Masson, Hugo L. P.
    Baumler, Andreas J.
    GUT MICROBES, 2023, 15 (01)
  • [24] New dawn of ginsenosides: regulating gut microbiota to treat metabolic syndrome
    Bai, Xue
    Fu, Rongzhan
    Deng, Jianjun
    Yang, Haixia
    Zhu, Chenhui
    Fan, Daidi
    PHYTOCHEMISTRY REVIEWS, 2024, 23 (04) : 1247 - 1269
  • [25] Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?
    Harris, Kristina
    Kassis, Amira
    Major, Genevieve
    Chou, Chieh J.
    JOURNAL OF OBESITY, 2012, 2012
  • [26] Gut Microbiota and Metabolic Syndrome: Relationships and Opportunities for New Therapeutic Strategies
    Ezenabor, Emmanuel Henry
    Adeyemi, Aishat Abimbola
    Adeyemi, Oluyomi Stephen
    SCIENTIFICA, 2024, 2024
  • [27] Gut microbiota and metabolic disease: from pathogenesis to new therapeutic strategies
    Kang, Yongbo
    Zhang, Xiaofang
    Cai, Yue
    Su, Junhong
    Kong, Xiangyang
    REVIEWS IN MEDICAL MICROBIOLOGY, 2016, 27 (04) : 141 - 152
  • [28] The role of gut microbiota in metabolic regulation
    Kravchuk, Ekaterina N.
    Neimark, Alexander E.
    Grineva, Elena N.
    Galagudza, Mikhail M.
    DIABETES MELLITUS, 2016, 19 (04): : 280 - 285
  • [29] Resveratrol, Metabolic Syndrome, and Gut Microbiota
    Chaplin, Alice
    Carpene, Christian
    Mercader, Josep
    NUTRIENTS, 2018, 10 (11)
  • [30] Gut Microbiota, Obesity" and Metabolic Dysfunction
    Methana, Anna
    Whaya, Andt
    INDONESIAN BIOMEDICAL JOURNAL, 2011, 3 (03): : 150 - 167